云南高校图书馆联盟文献共享服务平台- IPILIMUMAB

IPILIMUMAB: 作品数：44被引量：96H指数：7; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：谢宗宙林飞燕胡章国周严韩宝惠更多>>; 相关机构：海口市人民医院上海市胸科医院东南大学中国科学院更多>>; 相关期刊：《细胞与分子免疫学杂志》《华西医学》《Journal of Pharmaceutical Analysis》《临床皮肤科杂志》更多>>; 相关基金：国家自然科学基金北京市自然科学基金更多>>

卡博替尼和纳武单抗联合或不联合活菌补充治疗转移性肾细胞癌患者的临床研究: 《中国临床药理学杂志》2025年第4期600-600,共1页; CBM588(一种双歧因子益生菌活性产品)与接受纳武单抗和ipilimumab治疗的转移性肾透明细胞癌(metastatic renal cell carcinoma,mRCC)患者的临床结局改善相关。然而,其对接受酪氨酸激酶抑制药联合治疗的患者效果尚不明确。在该项开放标...; 关键词：纳武单抗 IPILIMUMAB 临床试验双歧因子益生菌

Long-Term Persistent Absolute Insulin Secretion Deficiency in Diabetes Induced by Immune Checkpoint Inhibitors: 《Open Journal of Endocrine and Metabolic Diseases》2023年第12期227-233,共7页Moctar Bah Clara Bouché Jean-François Gautier; Immune checkpoint inhibitors are today an immense hope in the management of cancers. However, since their widespread use, many cases of insulin-requiring diabetes appearing suddenly, as fulminant diabetes have been re...; 关键词：Immune Checkpoint Inhibitors Nivolumab IPILIMUMAB Fulminant Diabetes Insulin-Requiring Diabetes

A durable complete response resulting from treatment with nivolumab plus ipilimumab for metastatic collecting duct carcinoma of the kidney: 《Asian Journal of Urology》2023年第3期376-378,共3页Keisuke Funajima Sei Naito Takanobu Kabasawa Hayato Nishida Tomoyuki Kato Mitsuru Futakuchi Norihiko Tsuchiya; Dear Editor,Collecting duct carcinoma(CDC)or Bellini carcinoma originates in the distal collecting ducts.CDC is a markedly aggressive subtype of renal cell carcinoma and accounts for less than 1%of all renal cell carc...; 关键词：markedly nivolumab APPROVAL

Nivolumab plus ipilimumab:a potential regimen to rewrite treatment guidelines for ESCC: 《Signal Transduction and Targeted Therapy》2022年第6期1875-1877,共3页Yuejun Luo Nan Sun Jie He; supported by the Fundamental Research Funds for the Central Universities(3332018070);the National Key Basic Research Development Plan(2018YFC1312105);the Beijing Natural Science Foundation(J20010).; The recent research published in The New England Journal of Medicine by Y.Doki et al.has reported the interim findings from the CheckMate 648,which is an international,multi-center,openlabel,and randomized phase 3 cli...; 关键词：REGIMEN ESOPHAGEAL

Hypercalcemia and Granulomatous-Like Lesions in a Patient with Melanoma after Treatment with Immunotherapy: Case Report: 《Case Reports in Clinical Medicine》2022年第5期188-193,共6页Rebecca A. Takele Alya Z. Aboulhosn Prajwol Pant Paul Laflam; Checkpoint inhibitors, a subset of immunotherapies, are effective treatment modalities for cancers such as melanoma. However, they are not without possible adverse effects. Drug-induced reactions may present with simi...; 关键词：HYPERCALCEMIA Immune Checkpoint Inhibitors Drug-Induced Sarcoido-sis-Like Reaction IPILIMUMAB Nivolumab

Tsunami of immunotherapy reaches mesothelioma: 《World Journal of Clinical Oncology》2022年第4期267-275,共9页Xabier Mielgo-Rubio Ana Cardena Gutierrez Veronica Sotelo Pena Maria Virginia Sanchez Becerra Andrea Maria Gonzalez Lopez Adriana Rosero Juan Carlos Trujillo-Reyes Felipe Counago; Malignant pleural mesothelioma(MPM) is the most common type of malignant mesothelioma. It is a rare tumor linked to asbestos exposure and is associated with a poor prognosis. Until very recently, patients with advance...; 关键词：MESOTHELIOMA Malignant pleural mesothelioma IMMUNOTHERAPY Immune checkpoint inhibitors Cytotoxic T-lymphocyte–associated antigen 4 Programmed cell death protein 1 Nivolumab IPILIMUMAB Immunotherapy combo Check Mate 743 CONFIRM

Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma被引量：4: 《Journal of Cancer Metastasis and Treatment》2021年第1期532-550,共19页Michael T.Serzan Michael B.Atkins; The therapeutic landscape for advanced clear cell renal cell carcinoma(ccRCC)is rapidly evolving with improved knowledge of the biology of disease leading to the incorporation of a variety of antiangiogenic agents and...; 关键词：Renal cell carcinoma nivolumab IPILIMUMAB AXITINIB pembrolizumab avelumab biomarkers

The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship: 《Cancer Drug Resistance》2020年第4期699-709,共11页Irem Sahin Sevda Turen Pranav Santapuram Ibrahim Halil Sahin; Pancreatic cancer is one of the most aggressive cancers with a high mortality rate even among patients with early-stage disease.Although recent studies with novel therapeutic approaches have led to modest improvement ...; 关键词：Pancreatic adenocarcinoma durvalumab nivolumab IPILIMUMAB pembrolizumab immune checkpoint inhibitors immunotherapy resistance mismatch repair deficient microsatellite instability high microsatellite stable tumor-associated macrophages myeloid-derived suppressor cells T regs T cells

Immune checkpoint inhibitors induced colitis, stay vigilant: A case report: 《World Journal of Gastrointestinal Oncology》2020年第6期699-704,共6页Suha Abu Khalaf Abdulmajeed Albarrak Mohamad Yousef Veysel Tahan; BACKGROUND Colitis is one of the immune-related side effects of immunotherapy.Usually,such type of side effect was reported to develop within a few weeks of treatment initiation,our case started within a few days.CASE...; 关键词：Immunotherapy COLITIS MELANOMA Case report IPILIMUMAB Hepatitis

纳武利尤单抗联合伊匹木单抗一线治疗非小细胞肺癌的疗效被引量：7: 《循证医学》2020年第1期43-48,共6页董晓荣王千毓; 1文献来源研究一:Hellmann MD,Ciuleanu TE,Pluzanski A,et al.Nivolumab plus Ipilimumab in lung cancer with a high tumor mutational burden[J].N Engl J Med,2018,378(22):2093-2104.研究二:Hellmann MD,Paz-Ares L,Bernabe Caro ...; 关键词：非小细胞肺癌 Nivolumab IPILIMUMAB

IPILIMUMAB